That elevated TFAP2D expression was significantly associated with the majority of the analyzed deletions in ERG negative cancers highlights that elevated TFAP2D levels are either a cause or a consequence of genomic instability in prostate cancer cells. Here, TFAP2D is linked to prostate carcinoma.